Addressing a series of election rallies in support of his party's candidates in Jammu on the last day of campaigning, Azad voiced concerns over the promises made by various political parties regarding the return of Article 370 and said these promises are not grounded in reality.
Union Home Minister Amit Shah has declared that Chhattisgarh will be free from the menace of Naxalism by March 31, 2026. He stated that the Centre and the state government are committed to eradicating Naxalism, highlighting the significant achievements of the Chhattisgarh police in the last year. Shah also appealed to Naxalites to surrender and join the mainstream, emphasizing the government's rehabilitation policy. He further praised the Chhattisgarh police's efforts in curbing organized crime and narcotics.
Pharma major Nicholas Piramal India Ltd will develop and commercialise a select group of US-based Eli Lilly and Company's pre-clinical drug products that span multiple therapeutic areas.
'My one recommendation would be to first quell the violence and then encourage dialogue and build the trust among the different communities.' 'This is not easy but necessary, for violence cannot be the way forward.'
Nearly one in every two medical prescriptions issued in India deviated from standard guidelines, with approximately a tenth showing 'unacceptable deviations', a study, conducted by a team of researchers including those at the All India Institute of Medical Sciences (AIIMS) in New Delhi, has found.
Commercial launch and supply to major government and private hospitals is expected in mid-June.
Sinha called for justice to the victims as he blamed Pakistan for "still trying to kill innocent people" in the region to disrupt peace.
Treatment for arthritis is mainly focused on symptom management and slowing the progression of the disease, says Dr Vishal Shinde.
An international team, led by University of California, says that the KG5 drug works by making cancer cells "commit suicide"; it stops tumorous cells multiplying and they then shut themselves down, the 'Nature Medicine' journal reported.
Donald Trump's Presidency of the United States will open new opportunities for India though certain sectors, especially pharma and IT, may face the heat if the incoming president decides to impose restrictions on imports and H1B visa regulations, experts said on Wednesday. Prime Minister Narendra Modi's friendly relationship with Trump will have a positive bearing on Indo-US relations but India may have to adapt its strategies to maintain cooperation in areas of mutual interest.
Congress leader Rahul Gandhi on Thursday said Prime Minister Narendra Modi thinks that the Constitution of India is 'blank' because he has never read it.
The United Kingdom extracted USD 64.82 trillion from India over a century of colonialism between 1765 and 1900 and USD 33.8 trillion of this went to the richest 10 per cent -- enough money to carpet London in notes of 50 British pound almost four times over.
'It is not just the US and European opportunity, but it is a huge global opportunity.'
'A long-term investor with a 4 to 5 year horizon could invest in this theme via SIPs.'
Favipiravir is the only oral anti-viral treatment approved in India for potential treatment of patients with mild to moderate Covid-19 disease.
The show-cause notice dated February 8 by DCGI V G Somani cited a Delhi high court order dated December 12, 2018, which prohibits online sales of medicines without a licence.
Gland Pharma beat muted expectations for Q2FY25. There was increased Ebitda (Earnings before interest, taxes, depreciation and amortisation) loss at Cenexi, the CRAM subsidiary. However, overall Ebitda margin was better than expectations at 21.1 per cent. But given two years of earnings decline in FY23 and FY24, the business may have bottomed and upper-teens EPS (earnings per share) growth looks possible over next two financial years.
Seventeen persons, including four hailing from Taiwan, were arrested by Ahmedabad Cyber Crime Branch for allegedly operating a nationwide 'digital arrest' racket, a Gujarat police official said on Monday.
A Nasdaq-listed Israeli drug company has entered into an agreement with India's JB Chemicals and Pharmaceuticals to jointly develop products to improve its competitive edge in the US and other world markets.
Cancer has no race, so why do new innovative cancer drugs discriminate based on race and ethnic groups, asks Digonto Chatterjee.
Concerned about the rise of antibiotic resistance and the time it takes for drugs developed abroad to reach Indians, the government is considering holding its own clinical trials. Clinical trials for new drugs have so far primarily been conducted only by private Indian or foreign drug firms. But given the stringent nature of India's regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of global clinical trials take place in India.
State Ayurved Department's licence officer Y S Rawat said the notice is being issued to the firm to explain from where it got the permission to launch a 'corona kit' as a cure from the virus.
To burnish production-linked incentive (PLI) schemes, the government is considering an overhaul of some of them relating to sectors such as textiles and pharma, and making incentive payments quarterly, officials in the know said. In a bid to cut the delay in processing incentive claims, the government is looking at switching to a quarterly disbursement of incentives. Currently, in most schemes, incentives are annual.
Pharma major Nicholas Piramal India Ltd has claimed to have developed a novel anti-cancer drug to arrest and regulate the multiplication of cancer cells.
'Investors looking at the next 6-12 months can be certain that the Fed will maintain its easing cycle, and we expect the overall environment to be conducive for fixed income investments for portfolio diversification.'
Increasing band of expats is driving the Jubilant Organosys drug development and discovery business. Of the total 1,025 scientific manpower strength
'If someone fiddles us on our religion then we will pay back five times more to that person. We have proved that time and again.'
Arthritis affects people of all ages, including those in their 20s and 30s, says Dr Prashant Kamble, consultant-orthopedics at the Sir HN Reliance Foundation Hospital, Mumbai.
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
Niclosamide, a drug on the World Health Organisation's list of essential medicines, has been used to treat tapeworm infestation for more than 50 years. The oral antiviral drug was also used to treat patients during the SARS outbreak of 2003-04.
Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics
Pharma major, Dr Reddy's Laboratories Ltd on Wednesday said it will form an integrated drug development company 'Perlecan Pharma Pvt Ltd' with an equity capital of $52.5 million from two venture capital investors.
The TIME 100 AI list is an interesting assortment of titans. Indians make up about 20 per cent of the coveted list, which is pretty commendable, notes Sandeep Goyal.
Just as the atom and the byte needed careful societal control to prevent damage to society, perhaps, so does the gene, particularly in debates like 'genes vs merit', explains Ajit Balakrishnan.
'Afzal Guru became a victim of Pakistan's conspiracy. He was used as a means, just like all other innocent Kashmiris.'
Astronauts aboard the space station have found themselves facing a foe far tinier than any rogue asteroid: A joint study by IIT-Madras and NASA's Jet Propulsion Laboratory -- under Principal Investigator Kasthuri Venkateswaran -- has revealed that strains of the bacterial species Enterobacter bugandensis, a multi-drug resistant superbug, have been hitting the gym in the microgravity crucible. Though the situation at the ISS is slightly unsettling, holding funeral dirges would be an overkill, says Kumar Abishek.
Financial institutions are 300 times more vulnerable to cyberattacks than any other industry.
The Clinical Research sector is emerging as an attractive option for science graduates, doctors, management/ IT professionals, alike.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances